FIRM FIXED PRICENO SET ASIDE USED.
MARLEX PHARMACEUTICALS INC - NEW AWARD FOR ALENDRONATE TABLETS WITH MARLEX PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 5/21/2026 - 5/20/2027.
PIID: 36E79726D0016Solicitation ID: 36E79725R0069
Signed Date: Jan 7, 2026Effective Date: May 21, 2026
Key Details
Description
NEW AWARD FOR ALENDRONATE TABLETS WITH MARLEX PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 5/21/2026 - 5/20/2027.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.